Trials / Completed
CompletedNCT05055271
Delphi Consensus Excessive Daytime Sleepiness in OSA
Differential Diagnosis and Management of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea: A Modified Delphi Consensus Panel Report
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to generate expert consensus statements on the differential diagnosis, definition, and management of EDS in patients with OSA who are adequately treated with primary therapy.
Detailed description
A study will be performed using a modified Delphi process with an international expert panel to generate recommendation statements related to the differential diagnosis and management of patients with residual EDS in OSA (and relevant sub-topics) and to determine the level of agreement for each statement from the panel as a whole. The following topics will be covered: 1. EDS: definition, evaluation/assessment, and tools 2. Definitions of residual EDS in patients with OSA treated with primary OSA therapy 3. Practical recommendations 4. Management Consensus is achieved through iterative rounds of survey and revision to the statements until a pre-determined level of agreement is met (80% agreement). Part 1: planning and evidence review * Series of planning sessions with co-chairs and faculty leads * Literature is reviewed/summarized * Initial statements will be developed based on evidence Recommendation statements on EDS in OSA will be formulated and rated according to level of agreement on a 5-point Likert scale. Part 2: Survey to achieve consensus * Survey, based on the initial statements developed by faculty leads, will be developed to allow for vetting by full faculty group * At least 3 rounds of review (2 remote and 1 live \[virtual\]) will be held to achieve consensus on each topic of interest and finalize consensus statements
Conditions
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2022-09-12
- Completion
- 2022-09-12
- First posted
- 2021-09-24
- Last updated
- 2023-10-10
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05055271. Inclusion in this directory is not an endorsement.